Please log in to determine if you are eligible to purchase PT Programs.
SYNTHETIC CANNABINOID/DESIGNER DRUGS - SCDD
SCDD
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Analyte Challenges/Shipment Number of Shipments
Synthetic cannabinoid/designer drugs 3 Two shipments per year

SCDD Program Drug Listing. Challenges will include a mix of drugs. For the most current list of drugs, please go to cap.org. Click on Catalog and Shipping Information. The list is located under the PT Order Supplements header.


Additional Information

  • Synthetic cannabinoids and designer drug stimulants are widespread and constantly changing in respect to the available chemical moieties. In order to stay contemporary, the CAP has decided to modify the compounds in this program in accordance with the appearance and prevalence of new compounds.

Program Information

  • Three 20.0‑mL urine specimens
  • For laboratories that perform screening and confirmatory testing for the compounds found in this program

Shipping Schedule

  • Shipment A: April 1
  • Shipment B: September 23

Challenges will include a mix of drugs from the list below.
4-MEC (4-methylethcathinone)
5-Fluoro AMB metabolite 7
5F-PB-22 3-carboxyindole metabolite
AB-CHMINACA 3-methyl butanoic acid
AB-FUBINACA oxobutanoic acid
AB-PINACA N-pentanoic acid metabolite
ADB-PINACA N-pentanoic acid metabolite
AKB-48 N-pentanoic acid metabolite
Alpha-PVP (α-Pyrrolidinopentiophenone)
AM-2201 N-(4-hydroxypentyl) metabolite
Butylone
Ethylone
MAB-CHMINACA metabolite M2
MAM 2201 pentanoic acid metabolite
Mephedrone
Methylenedioxypyrovalerone (MDPV)
Methylone
Naphyrone
PB-22 3-carboxyindole metabolite
Pentylone
UR-144 N-pentanoic acid metabolite
XLR-11 4-hydroxypentyl metabolite>